share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher

SEC announcement ·  Apr 6 05:49
Summary by Futu AI
Recursion Pharmaceuticals CEO Christopher Gibson completed a series of transactions involving the company's Class A Common Stock. On April 3 and 4, 2024, Gibson sold a total of 105,000 shares directly and indirectly through entities such as the Gibson Family Trust and LAHWRAN-3 LLC. The sales occurred at prices ranging from $8.84 to $9.02 per share, resulting in a total market value of $714,400 for the direct sales. After these transactions, Gibson directly holds 938,524 shares. Additionally, 50,000 shares were acquired indirectly by the Gibson Family Trust and LAHWRAN-3 LLC, which were then sold at similar price points, totaling $446,500 in market value. The transactions have been reported as completed.
Recursion Pharmaceuticals CEO Christopher Gibson completed a series of transactions involving the company's Class A Common Stock. On April 3 and 4, 2024, Gibson sold a total of 105,000 shares directly and indirectly through entities such as the Gibson Family Trust and LAHWRAN-3 LLC. The sales occurred at prices ranging from $8.84 to $9.02 per share, resulting in a total market value of $714,400 for the direct sales. After these transactions, Gibson directly holds 938,524 shares. Additionally, 50,000 shares were acquired indirectly by the Gibson Family Trust and LAHWRAN-3 LLC, which were then sold at similar price points, totaling $446,500 in market value. The transactions have been reported as completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.